When a drug is proven not to work we might expect that doctors would finally stop prescribing it. And while a review of prescptions of Zetia, published in the American Heart Journal, found prescription rates falling by over 47% after studies showed the drug did not work, it still meant that Ezitamide sales were in the billions. In 2008 alone Merck reported sales of 4.9 billion dollars in drugs that contained Ezitamide.

When a drug is proven not to work we might expect that doctors would finally stop prescribing it. And while a review of prescptions of Zetia, published in the American Heart Journal, found prescription rates falling by over 47% after studies showed the drug did not work, it still meant that Ezitamide sales were in the billions. In 2008 alone Merck reported sales of 4.9 billion dollars in drugs that contained Ezitamide.

When a drug is proven not to work we might expect that doctors would finally stop prescribing it. And while a review of prescptions of Zetia, published in the American Heart Journal, found prescription rates falling by over 47% after studies showed the drug did not work, it still meant that Ezitamide sales were in the billions. In 2008 alone Merck reported sales of 4.9 billion dollars in drugs that contained Ezitamide.

When a drug is proven not to work we might expect that doctors would finally stop prescribing it. And while a review of prescptions of Zetia, published in the American Heart Journal, found prescription rates falling by over 47% after studies showed the drug did not work, it still meant that Ezitamide sales were in the billions. In 2008 alone Merck reported sales of 4.9 billion dollars in drugs that contained Ezitamide.

When a drug is proven not to work we might expect that doctors would finally stop prescribing it. And while a review of prescptions of Zetia, published in the American Heart Journal, found prescription rates falling by over 47% after studies showed the drug did not work, it still meant that Ezitamide sales were in the billions. In 2008 alone Merck reported sales of 4.9 billion dollars in drugs that contained Ezitamide.